Every 8-K that NextPlat Equity Warrants Exp 29th Apr 2026 (NXPLW) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow NXPLW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NXPLW filings page.
NextPlat Corp reported first quarter 2026 revenue of about $9.9 million, down from roughly $13.9 million a year earlier, mainly from lower healthcare revenue. Despite this, profitability improved as consolidated gross margin reached a quarterly record of about 35%, up from roughly 21%.
Healthcare pharmacy prescription revenue fell to about $4.8 million from $9.5 million, while pharmacy contract revenue rose to about $1.9 million from $1.4 million and e-commerce revenue edged up to about $3.2 million from $3.0 million. Total operating expenses declined about 9% to roughly $4.5 million.
Net loss attributable to common stockholders narrowed to about $1.1 million, or ($0.42) per share, compared with about $1.9 million, or ($0.75) per share, in the prior-year quarter. NextPlat ended March 31, 2026 with roughly $11.0 million in cash, about $14.2 million of working capital and total liabilities of approximately $10.3 million, and management targets positive operating income in the latter half of 2026.
NextPlat Corp shared preliminary expectations for its first quarter 2026 results, pointing to a continuing turnaround driven mainly by contracted healthcare services. The company expects Q1 2026 gross margins to rise to 34+% and operating expenses to decline by 8+% from Q4 2025.
First quarter consolidated gross profit is expected to increase by about 40% versus Q4 2025 as the business shifts toward higher-margin contracted healthcare revenue. NextPlat also reports a record number of added 340B entities, supporting anticipated healthcare services revenue growth and margin expansion through 2026, and is targeting positive operating income in the third quarter.
NextPlat Corp has regained compliance with Nasdaq’s minimum bid price rules, removing a prior delisting risk. The company had previously been notified that its stock traded below $1.00 for 30 straight trading days, triggering a grace period to cure the deficiency.
Nasdaq later confirmed that, for the 10 consecutive business days from April 13, 2026 to April 24, 2026, NextPlat’s closing bid price was at or above $1.00 per share. As a result, Nasdaq issued a compliance letter on April 27, 2026, closed the matter, and NextPlat remains listed on The Nasdaq Capital Market under the ticker “NXPL”.
NextPlat Corp is implementing a 1-for-10 reverse stock split of its common stock, effective at 12:01 a.m. Eastern Time on April 13, 2026. Every 10 existing shares will be combined into 1 share, with par value staying at $0.0001.
The reverse split will reduce outstanding common shares from approximately 26.9 million to approximately 2.7 million, while authorized shares remain at 50 million. Stock options, warrants and equity plan reserves will be adjusted proportionately, increasing exercise prices and reducing underlying share amounts. No fractional shares will be issued; instead, holders will receive cash based on the Nasdaq closing price on the effective date.
NextPlat’s stock is expected to begin trading on a split-adjusted basis on April 13, 2026 under the symbol “NXPL” with a new CUSIP number. Historical per-share figures, including net loss per share, have been recast to reflect the new share count for 2025 and 2024.
NextPlat Corp reported full-year 2025 revenue of approximately $54.3 million, down 18% from about $66.1 million in 2024, as healthcare prescription volumes declined but e-commerce grew modestly. Healthcare revenue fell to $39.7 million from $52.3 million, driven by fewer prescriptions and lower 340B contract revenue, partly offset by higher reimbursement per script.
e-Commerce revenue increased to $14.6 million from $13.8 million on stronger airtime and hardware sales and favorable foreign exchange. Overall gross margin declined to about 20% from 26%, but total operating expenses were cut roughly in half to $19.9 million from $40.0 million, reflecting cost reductions and the absence of a prior-year impairment loss. Net loss attributable to common stockholders narrowed to approximately $11.7 million, or $0.44 per share, from $13.4 million, or $0.65 per share. The company ended 2025 with about $13.7 million in cash and roughly $15.0 million in working capital.
NextPlat Corp reported that on September 3, 2025 its Board appointed Rodney Barreto as Chairman and David Phipps as Chief Executive Officer, converting each from their interim roles following the May 2025 death of former Executive Chairman and CEO Charles M. Fernandez. Mr. Barreto had served as Interim Chairman and Mr. Phipps had served as Interim Chief Executive Officer since May.
The company states that Mr. Phipps’s existing employment agreement remains unchanged at the time of his permanent appointment. The company issued a press release on September 9, 2025 announcing the appointments and filed that release as Exhibit 99.1 to this Current Report.
NextPlat Corp furnished a press release announcing financial results for the quarter ended June 30, 2025. The press release is provided as Exhibit 99.1 and the filing also references a Cover Page Interactive Data File (Exhibit 104). The company states the information in the release is furnished and is not incorporated by reference into other filings and is not deemed to be "filed" for purposes of Section 18 of the Exchange Act or subject to liability under Sections 11 and 12(a)(2) of the Securities Act.
This report therefore notifies the market that quarter-end results were released but does not itself include those results within the body of the filing.